Pharmacogenetics of Type 2 Diabetes—Progress and Prospects

by Yulia A. Nasykhova, Ziravard N. Tonyan, Anastasiia A. Mikhailova, Maria M. Danilova, Andrey S. Glotov
Published 2020-09-01

Whole‐exome sequencing provides insights into monogenic disease prevalence in Northwest Russia

by Yury A. Barbitoff, Rostislav K. Skitchenko, Olga I. Poleshchuk, Anton E. Shikov, Elena A. Serebryakova, Yulia A. Nasykhova, Dmitrii E. Polev, Anna R. Shuvalova, Irina V. Shcherbakova, Mikhail A. Fedyakov, Oleg S. Glotov, Andrey S. Glotov, Alexander V. Predeus
Published 2019-11-01

Identification of Novel Candidate Markers of Type 2 Diabetes and Obesity in Russia by Exome Sequencing with a Limited Sample Size

by Yury A. Barbitoff, Elena A. Serebryakova, Yulia A. Nasykhova, Alexander V. Predeus, Dmitrii E. Polev, Anna R. Shuvalova, Evgenii V. Vasiliev, Stanislav P. Urazov, Andrey M. Sarana, Sergey G. Scherbak, Dmitrii V. Gladyshev, Maria S. Pokrovskaya, Oksana V. Sivakova, Aleksey N. Meshkov, Oxana M. Drapkina, Oleg S. Glotov, Andrey S. Glotov
Published 2018-08-01

Analysis of the Spectrum of ACE2 Variation Suggests a Possible Influence of Rare and Common Variants on Susceptibility to COVID-19 and Severity of Outcome

by Anton E. Shikov, Anton E. Shikov, Yury A. Barbitoff, Yury A. Barbitoff, Yury A. Barbitoff, Andrey S. Glotov, Andrey S. Glotov, Maria M. Danilova, Ziravard N. Tonyan, Yulia A. Nasykhova, Anastasia A. Mikhailova, Olesya N. Bespalova, Roman S. Kalinin, Azizahon M. Mirzorustamova, Igor Yu Kogan, Vladislav S. Baranov, Vladislav S. Baranov, Alexander N. Chernov, Dragana M. Pavlovich, Sergey V. Azarenko, Mikhail A. Fedyakov, Victoria V. Tsay, Yuri A. Eismont, Olga V. Romanova, Dmitry N. Hobotnikov, Dmitry A. Vologzhanin, Sergei V. Mosenko, Tatiana A. Ponomareva, Yana A. Talts, Anna U. Anisenkova, Dmitrii G. Lisovets, Andrey M. Sarana, Stanislav P. Urazov, Sergey G. Scherbak, Sergey G. Scherbak, Oleg S. Glotov, Oleg S. Glotov
Published 2020-09-01